Cold coagulation uses heat
The probe transfers heat to the target tissue. Cold coagulation is not freezing or cryotherapy.
WISAP
WISAP Cervix Coagulator 6001 | Cervical Thermal Ablation
Model 6001
WISAP 6001, also known as the Cold Coagulator, is an electrically powered cervical thermal treatment system with a 60–120°C range and selectable therapy probes. Intended for appropriately assessed patients within the supplied system’s indications.
PRODUCT HIGHLIGHTS
Product highlights
Stepless temperature regulation
A 60–120°C adjustment range supports selection according to the probe, intended use and applicable instructions.
Select the appropriate therapy probe
Different probe designs address different contact areas and applications. Specify the exact reference for the procedure.
Plan the clinic configuration
The 3.6 kg unit uses mains power and an instrument cable. Plan the power supply and validated probe-care workflow.
TECHNICAL SPECIFICATIONS
Technical specifications
| Specification | Details / value and unit |
|---|---|
| Model / reference | 6001 |
| Temperature range | 60–120°C |
| Temperature regulation | Stepless |
| Standard mains supply | 230 V · 50/60 Hz |
| Power input | 66 VA |
| Dimensions W×H×D | 270 × 120 × 190 mm |
| Weight | 3.6 kg |
| Housing | Stainless steel / coated aluminium |
| Instrument cable | 6020 · 1.5 m |
EQUIPMENT & ACCESSORIES
Equipment & accessories
- 6001 · Control unit and power cord
Confirm the mains voltage and country-specific power cord in the quotation.
- 6020 · Instrument cable
Orange silicone cable with two coupling plugs, 1.5 m long. Confirm whether included or supplied separately.
- Therapy probes · Order by reference
The supplied literature includes 6002–6009 and a 6010 option in another selection. Confirm the current design, intended use and quantity; all probes are not automatically included.
ADDITIONAL INFORMATION
Additional information
Role in cervical lesion management
Thermal treatment destroys target tissue in appropriately selected cervical ablation cases. CIN grade and HPV results inform assessment; neither automatically makes every patient eligible.
Assess eligibility before ablation
Assess transformation-zone and lesion visibility and whether the probe can reach the treatment area. Suspected invasive cancer or glandular disease requires appropriate evaluation rather than ablation in place of diagnosis.
Thermal ablation versus LEEP
Ablation destroys the target tissue; LEEP/LLETZ excises tissue for histological examination. Selection depends on diagnostic needs, lesion extent and the clinical plan.
Haemostasis after conisation
Probe options include haemostasis applications after conisation or LEEP/LLETZ where supported. Specify this application separately from precancer ablation.
Prepare the complete configuration
Specify the 6001 unit, voltage, cable 6020 and probe references and quantities, together with validated reprocessing, training, acceptance and maintenance requirements.
Further details
References
WISAP Cervix Coagulator 6001 and Cold Coagulator product literature
https://wisap.de/thermo-coagulation/
WHO: thermal ablation for cervical pre-cancer lesions
https://www.who.int/publications-detail-redirect/9789241550598
Reviewed 10 November 2026. Confirm current labelling and the supplied model’s IFU.
คำถามที่พบบ่อย / FAQ
Does cold coagulation use cold or heat?
It applies heat through a probe. Despite the name, it is not cryotherapy or freezing.
Is WISAP 6001 battery powered?
The 6001 is mains powered, with standard 230 V 50/60 Hz supply. Do not substitute C3 or other model specifications.
Does every CIN lesion require this treatment?
No. Surveillance, biopsy, excision or ablation is selected according to diagnosis and guidelines. A CIN 1–3 product description does not replace individual assessment.
Does it eradicate HPV or treat invasive cervical cancer?
No such assurance should be given. Lesion ablation does not guarantee HPV eradication and is not a substitute for invasive-cancer treatment. Follow-up remains necessary.
What time and temperature should be selected?
Use the applicable indication, probe and model-specific IFU. The device’s adjustment range is not a universal patient treatment setting.
Are the probes and cable 6020 included?
Confirm the unit, cable and selected probe references separately. Product images do not establish that every component is included.
How should the probes be reprocessed?
Follow the validated method for the exact probe and cable. Care of the control unit is separate; do not assume one process applies to all components.
RELATED KNOWLEDGE
Read more about this workflow
HyaRegen: Gynecological adhesion barriers
Explore HyaRegen crosslinked HA adhesion barrier gel for gynecological surgery: features, clinical evidence and the 10 mL presentation.
Read article
MateRegen: Care after intrauterine procedures
Meet MateRegen crosslinked HA gel for intrauterine adhesion barriers: hysteroscopic use, clinical evidence and 3 mL / 5 mL presentations.
Read article
Choose stirrups and leg holders for your workflow
Compare patient groups, adjustment axes, boots, pads, clamps and quotation scope with Herbert ST103T, ST130TK and gynecology/APT leg-holder information.
Read articleFind the right solution for your organization
Contact our team to confirm models, specifications, equipment and supply terms.